St. Johns Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Hold |
50
| – | – | 0.01% | 122 |
|
|
2025
Q1 | $13.5K | Hold |
50
| – | – | 0.01% | 120 |
|
|
2024
Q4 | $11.8K | Hold |
50
| – | – | 0.01% | 125 |
|
|
2024
Q3 | $13.8K | Hold |
50
| – | – | 0.01% | 135 |
|
|
2024
Q2 | $12.2K | Hold |
50
| – | – | 0.01% | 121 |
|
|
2024
Q1 | $7.47K | Hold |
50
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $9.57K | Hold |
50
| – | – | ﹤0.01% | 128 |
|
|
2023
Q3 | $8.86K | Hold |
50
| – | – | 0.01% | 126 |
|
|
2023
Q2 | $9.5K | Hold |
50
| – | – | 0.01% | 130 |
|
|
2023
Q1 | $10K | Hold |
50
| – | – | 0.01% | 119 |
|
|
2022
Q4 | $11.9K | Hold |
50
| – | – | 0.01% | 112 |
|
|
2022
Q3 | $10K | Hold |
50
| – | – | 0.01% | 117 |
|
|
2022
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 120 |
|
|
2022
Q1 | $8K | Hold |
50
| – | – | ﹤0.01% | 130 |
|
|
2021
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 141 |
|
|
2021
Q3 | $9K | Hold |
50
| – | – | 0.01% | 124 |
|
|
2021
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 125 |
|
|
2021
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 124 |
|
|
2020
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 125 |
|
|
2020
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 121 |
|
|
2020
Q2 | $7K | Buy |
+50
| New | +$7K | 0.01% | 118 |
|